Latest filing published 30 Aug 2021 for Rossari Biotech Limited, €7,864.
Filing timeline
BuySaleSudhir Sawant: trading record in brief
This profile gathers the share dealings of Sudhir Sawant in Rossari Biotech Limited, where the filings describe the role as chief executive. Between 17 July 2021 and 9 August 2021, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 30 August 2021: a transaction of €7,864, in Rossari Biotech Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sudhir Sawant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ ₹1,376.250.0000% mcap15.6% of flowEquity SharesSEBI:aa9a07d8e523ba149f64e83935a07dd7f9c02089
- 1,000 shares@ ₹1,289.150.0001% mcap29.1% of flowEquity SharesSEBI:5c7a028f815b064dfa63ce7c62bf4ea480dc831b
- 1,000 shares@ ₹1,289.150.0001% mcap29.0% of flowEquity SharesSEBI:0eb000494d3367d9a21ab1f51d6c7192adf83757
- 1,000 shares@ ₹1,167.450.0001% mcap26.3% of flowEquity SharesSEBI:55b08d8766522d29b8a9a4d19ecc2dccec2f728fCanonical exit: 15 Oct 2021 (T+90)
4 of 4 declarations